S&P 500   3,001.81 (+0.52%)
DOW   26,791.90 (+0.08%)
QQQ   192.94 (+0.65%)
AAPL   240.87 (+1.89%)
FB   189.16 (+1.78%)
MSFT   137.37 (-0.03%)
GOOGL   1,245.60 (+0.09%)
AMZN   1,779.63 (+1.26%)
CGC   20.05 (-0.79%)
NVDA   195.82 (+2.80%)
MU   44.91 (+3.31%)
TSLA   254.39 (-1.00%)
AMD   32.08 (+3.58%)
T   38.38 (-0.23%)
F   9.11 (-1.94%)
ACB   3.62 (-1.63%)
NFLX   276.93 (+0.59%)
BAC   31.13 (+2.54%)
GILD   65.02 (+0.17%)
DIS   130.78 (-0.08%)
S&P 500   3,001.81 (+0.52%)
DOW   26,791.90 (+0.08%)
QQQ   192.94 (+0.65%)
AAPL   240.87 (+1.89%)
FB   189.16 (+1.78%)
MSFT   137.37 (-0.03%)
GOOGL   1,245.60 (+0.09%)
AMZN   1,779.63 (+1.26%)
CGC   20.05 (-0.79%)
NVDA   195.82 (+2.80%)
MU   44.91 (+3.31%)
TSLA   254.39 (-1.00%)
AMD   32.08 (+3.58%)
T   38.38 (-0.23%)
F   9.11 (-1.94%)
ACB   3.62 (-1.63%)
NFLX   276.93 (+0.59%)
BAC   31.13 (+2.54%)
GILD   65.02 (+0.17%)
DIS   130.78 (-0.08%)
Log in

Clinigen Group Stock Price, News & Analysis (LON:CLIN)

GBX 799.50
-6.00 (-0.74 %)
(As of 10/21/2019 12:02 PM ET)
Today's Range
793.50
Now: GBX 799.50
814.05
50-Day Range
805.50
MA: GBX 880.53
953
52-Week Range
716
Now: GBX 799.50
1,069
Volume283,144 shs
Average Volume432,646 shs
Market Capitalization£1.06 billion
P/E Ratio199.88
Dividend Yield0.81%
BetaN/A
Clinigen Group plc operates as a specialty pharmaceutical and services company. The company operates through three segments: Commercial Medicines, Unlicensed Medicines, and Clinical Trial Services. The Commercial Medicines segment acquires and licenses commercial medicines and then revitalises them, as well as provides access to licensed and branded generic medicines in the Africa and Asia Pacific region. Read More…

Industry, Sector and Symbol

Industry Drug Delivery
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1283-495010

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£456.90 million
Cash FlowGBX 61.52 per share
Book ValueGBX 331.10 per share

Profitability

Miscellaneous

Employees849
Market Cap£1.06 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive CLIN News and Ratings via Email

Sign-up to receive the latest news and ratings for CLIN and its competitors with MarketBeat's FREE daily newsletter.


Clinigen Group (LON:CLIN) Frequently Asked Questions

What is Clinigen Group's stock symbol?

Clinigen Group trades on the London Stock Exchange (LON) under the ticker symbol "CLIN."

How often does Clinigen Group pay dividends? What is the dividend yield for Clinigen Group?

Clinigen Group announced a dividend on Thursday, September 19th. Shareholders of record on Thursday, November 7th will be paid a dividend of GBX 4.75 per share on Friday, November 29th. This represents a yield of 0.51%. The ex-dividend date of this dividend is Thursday, November 7th. This is a boost from Clinigen Group's previous dividend of $1.95. The official announcement can be accessed at this link. View Clinigen Group's Dividend History.

How were Clinigen Group's earnings last quarter?

Clinigen Group PLC (LON:CLIN) issued its quarterly earnings results on Tuesday, February, 27th. The company reported $21.20 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $20.30 by $0.90. The firm earned $167.80 million during the quarter. View Clinigen Group's Earnings History.

What price target have analysts set for CLIN?

5 equities research analysts have issued 12 month target prices for Clinigen Group's shares. Their predictions range from GBX 1,000 to GBX 1,640. On average, they expect Clinigen Group's stock price to reach GBX 1,295 in the next twelve months. This suggests a possible upside of 62.0% from the stock's current price. View Analyst Price Targets for Clinigen Group.

What is the consensus analysts' recommendation for Clinigen Group?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clinigen Group in the last year. There are currently 1 hold rating, 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Clinigen Group.

Has Clinigen Group been receiving favorable news coverage?

News headlines about CLIN stock have trended somewhat positive on Monday, InfoTrie reports. The research group identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Clinigen Group earned a news sentiment score of 0.8 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Clinigen Group.

Who are some of Clinigen Group's key competitors?

What other stocks do shareholders of Clinigen Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Clinigen Group investors own include Comerica (CMA), Honda Motor (HMC), Advanced Accelerator Application (AAAP), First Hawaiian (FHB), Landec (LNDC), NII (NIHD), Albemarle (ALB), RTI International Metals (RTI), NetApp (NTAP) and StatPro Group (SOG).

Who are Clinigen Group's key executives?

Clinigen Group's management team includes the folowing people:
  • Mr. Shaun Edward Chilton, CEO & Exec. Director (Age 51)
  • Mr. Nicholas Keher, CFO & Director
  • Ms. Debra Ainge, Chief Operating Officer
  • Matt Parrish, Head of Investor Relations
  • Mr. David Bryant, Director of Corp. Devel.

How do I buy shares of Clinigen Group?

Shares of CLIN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Clinigen Group's stock price today?

One share of CLIN stock can currently be purchased for approximately GBX 799.50.

How big of a company is Clinigen Group?

Clinigen Group has a market capitalization of £1.06 billion and generates £456.90 million in revenue each year. Clinigen Group employs 849 workers across the globe.View Additional Information About Clinigen Group.

What is Clinigen Group's official website?

The official website for Clinigen Group is http://www.clinigengroup.com/.

How can I contact Clinigen Group?

Clinigen Group's mailing address is Pitcairn House Crown Square, First Avenue, STAFFORDSHIRE, DE14 2WW, United Kingdom. The company can be reached via phone at +44-1283-495010.


MarketBeat Community Rating for Clinigen Group (LON CLIN)

Community Ranking:  3.9 out of 5 (star star star)
Outperform Votes:  390 (Vote Outperform)
Underperform Votes:  107 (Vote Underperform)
Total Votes:  497
MarketBeat's community ratings are surveys of what our community members think about Clinigen Group and other stocks. Vote "Outperform" if you believe CLIN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLIN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel